CGEN vs CLGN: Side-by-Side Comparison
Compare Compugen Ltd (CGEN) and CollPlant Biotechnologies Ltd New (CLGN) side by side: market cap USD 215.58M vs USD 4.91M. Financials, growth and model signals on Bullrun.
| Metric | CGEN | CLGN |
|---|---|---|
| Company | Compugen Ltd | CollPlant Biotechnologies Ltd New |
| Country / Exchange | Israel · NASDAQ | Israel · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | USD 215.58M | USD 4.91M |
| P/E ratio | 6.2 | — |
| Dividend yield | — | — |
| Valuation model | 101.6% undervalued | — |
| Revenue (FY2025) | USD 72.76M | USD 2.37M |
| Revenue growth YoY | +161.1% | +360.4% |
| Net income | USD 35.34M | USD -11.49M |
| Gross margin | 87.3% | 64.8% |
| Diluted EPS | 0.38 | -0.94 |